The literature offers discordant results regarding whether diagnostic biopsy is associated with the dissemination of cancer cells, resulting in local and/or distant metastasis. The long-term outcomes of patients with breast cancer were compared between those who were diagnosed using either fine-needle aspiration biopsy (FNAB) or core-needle biopsy (CNB) during 2 decades: the 1970s and 1990s. METHODS: In the 1970s, the only diagnostic needle biopsy method used for breast cancer in Sweden was FNAB. CNB was introduced 1989 and became established in Stockholm Gotland County in the early 1990s. The authors compared the clinical outcomes of patients diagnosed using FNAB from 1971 to 1976 (n 5 354) versus those of patients diagnosed using CNB from 1991 to 1995 (n 5 1729). Adjusting for differences in various treatment modalities, mammography screening, tumor size, DNA ploidy, and patient age between the 2 decades, 2 strictly matched samples representing FNAB (n 5 181) and CNB (n 5 203) were selected for a 15-year follow-up study. RESULTS: In a comparison of the rates of distant metastasis in the strictly matched patient groups from the FNAB and CNB cohorts, significantly higher rates of late-appearing (5-15 years after diagnosis) distant metastasis were observed among the patients who were diagnosed on CNB compared with those who were diagnosed on FNAB. No significant difference in local metastasis was observed between the 2 groups. CONCLUSIONS: At 5 to 15 years after diagnosis of the primary tumor, CNBdiagnosed patients had significantly higher rates of distant metastases than FNAB-diagnosed patients. Cancer Cytopathol 2017;125:748-56.
INTRODUCTION
Cell or tissue biopsy is required to obtain a conclusive diagnosis of potentially malignant breast lesions in the vast majority of patients. For this purpose, core-needle biopsy (CNB) is currently established as the most frequently used diagnostic method worldwide, whereas fine-needle aspiration biopsy (FNAB) and surgical biopsy are less commonly used.
The use of FNAB was first reported as early as 1847 for head and neck cancers. 1 However, FNAB became established in clinical practice at the Memorial Sloan Kettering Cancer Center in the 1930s, 2 but it was not widely used in other clinics, and its safety was regarded as controversial at that time. 3 During the 1950s and 1960s, FNAB became customary in Scandinavia and was established as a gold-standard procedure that was assumed to be safe, reliable, and inexpensive. A very early breast cancer study from 1962, using excision or incision surgery only or preceded by needle biopsy, revealed no difference in survival between matched groups for the 3 treatment groups with breast cancer who were followed up to 15 years. 4 In the 1980s, CNB began to replace FNAB in Sweden as a safe and effective alternative with high sensitivity and specificity rates. A recent evaluation of the positive and negative predictive values and sensitivity and specificity rates using the same tumor masses revealed that both FNAB and CNB had high sensitivities and specificities, with an overall accuracy of 74.4% (FNAB) and 80.7% (CNB). 5 CNB also offers the possibility of retrieving tissue with a preserved microscopic architecture for histologic assessment and achieves an accurate, conclusive diagnosis in most cases. A study on rabbits performed in Sweden in the 1970s, when FNAB was the only available biopsy method, demonstrated no strong evidence of tumor cell seeding after an analysis of the efferent lymph and blood vessels that drained the tumor mass. 6 Although some authors have observed tumor cells in needle tracts and/or blood and lymph vessels after CNB, [7] [8] [9] [10] others have observed no needle tract seeding in image-guided CNB. 11 Hansen et al 12 studied matched patient cohorts who had undergone FNAB or CNB or had received treatment with breast-conserving surgery without preceding needle biopsies. Those authors observed a significantly increased incidence of tumor cells in the sentinel lymph nodes (SLNs) after CNB and a positive trend after FNAB compared with the incidence among women who underwent surgery without a preceding biopsy, and their result was independent of age, tumor size, and tumor grade in multivariate analysis. That finding was contradicted by a prospective multicenter study of SLNs in which the biopsy type, including CNB, FNAB, and incisional biopsy, was not associated with SLNs. 13 In another breast cancer study, tumor cell displacement after CNB declined as the time increased between CNB and surgical excision; the authors concluded that disseminated cells do not survive in the long term. 14 A meta-analysis of 269 publications involving 421,744 patients revealed reports of needle tract seeding. However, because no control groups were used, the conclusions regarding biopsy-induced distant metastases (DISTMs) could not be made. 15 Another systematic review demonstrated that, from 1990 to 2008, displaced breast tumor epithelial cells were identified after CNB in 22% of patients. However, the investigators concluded that no increased morbidity was associated with iatrogenic seeding, at least partially based on the finding that an increased time interval between CNB and surgical excision reduced the percentage of patients who had detectable displaced tumor cells, suggesting lack of viability of the displaced cells. 16 In a breast cancer mouse model, inflammation was induced by 2-mm punch/CNB, resulting in a 3-fold to 5-fold increase in lung metastasis compared with control mice. 17 Those studies indicate that, in strictly controlled experiments on animals, needle biopsies give rise to inflammatory reactions and influence the frequency of both local metastases (LOCMs) and DISTMs. 17, 18 In human breast cancer, however, multiple confounding parameters may complicate the assessment of needle biopsy-induced tumor cell displacement and the establishment of metastasis.
In the current study, we analyzed the numbers of patients who had LOCMs and DISTMs in 2 matched groups who were diagnosed using either FNAB or CNB. Patients in both groups were followed for 15 years after diagnosis.
MATERIALS AND METHODS

Sample Data
To compare FNAB and CNB from the 2 decades (1970s and 1990s), which represented the 2 diagnostic methods, we obtained retrospectively randomized patient data, including clinical follow-up information, from the Stockholm Regional Oncologic Center from 1971 to 1976 (n 5 354) and from 1991 to 1995 (n 5 1729). From those data, we selected matched subgroups for comparison. Patients who had received chemotherapy and hormone treatments were excluded (see below), and those who had undergone either surgery plus postoperative radiotherapy or surgery alone were included. Consequently, we assessed 230 patients registered in the FNAB cohort and 219 patients registered in the CNB cohort (see below). Mammography screening was implemented in 1989 in Stockholm Gotland County for women ages 50 to 69 years who underwent screening at 2-year intervals. Women who had tumors measuring 30 mm in greatest dimension were included in this study (see below).
We recorded LOCMs and DISTMs occurring up to 180 months after diagnosis (15 years) for all patients. Follow-up data were acquired through the population-based Swedish national registry, which records primary diagnosis, local and distant recurrences, as well as diseasespecific deaths.
LOCMs that were not present at diagnosis were defined as tumor in the ipsilateral breast or ipsilateral chest wall, regional metastases in ipsilateral axillary lymph nodes or neck in the supraclavicular region. DISTMs were defined as metastases in the contralateral breast, contralateral and distant lymph nodes, bone, lung, pleura, mediastinum, liver, skin, brain, ovaries, or abdomen without further specification as well as other unspecified, distant regions.
Matched Subgroups for Comparison
Patients who were diagnosed in the 1970s either received treatment with preoperative (n 5 124) or postoperative (n 5 118) radiotherapy or underwent surgery alone (n 5 112). Because only postoperative radiotherapy was used in the 1990s, the sample from the 1970s included only those who underwent surgery alone or surgery plus postoperative radiotherapy (n 5 230) to achieve an optimal match of the 2 patient cohorts. Among the treatments used during the 1990s, we selected surgery alone (n 5 71) and surgery combined with postoperative radiotherapy (n 5 148) for all 219 patients to avoid confounding effects of adjuvant chemotherapy and hormone therapy. Because mammography screening results in earlier detection (ie, the detection of smaller tumors at diagnosis), we registered the tumor size of each patient. We observed differences in size distribution between the CNB and FNAB cohorts only in tumors that measured >30 mm in greatest dimension. Because of this finding, we excluded tumors >30 mm from the study. In total, after considering tumor size, there were 181 patients in the FNA cohort and 203 patients in the CNB cohort (see Results, below).
DNA Ploidy Analysis
Tumor material from patients who were diagnosed in the 1970s and 1990s was routinely analyzed regarding DNA content. DNA measurements were performed using image cytometric analysis of Feulgen-stained cells. 19, 20 The DNA histogram patterns were characterized by their DNA indices interval, as defined in 1970s, and were classified into diploid, tetraploid, and aneuploid subgroups.
Biopsy Needle Diameters and Gauges
The outer diameter of the needle used for FNAB ranges from 0.5 to 0.7 mm (25-gauge or 22-gauge), whereas that of the needle used for CNB ranges from 1.25 to 3.00 mm (18-gauge or 11-gauge) and may be even larger. The mean numbers of samples taken from each breast lesion were 3 for FNAB and 3 or 4 for CNB. Finally, damaged blood vessels will cause semi-static lesion pressure, which, for CNB, may include a volume up to approximately 1 cm 3 with a pressure of approximately 120 mm Hg (1.6 mH 2 O or 0.16 Bar), potentially causing emissions of blood and cellular material during low-pressure phases until the pressure is again balanced.
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Statistical Analysis
Statistical analysis was performed using the STATISTICA software package (StatSoft Inc, Tulsa, Oklahoma). The statistical significance of categorical variables was calculated using the chi-square test, and differences between mean values were estimated using an independent t test. P values were computed based on the t value for receptive comparison of differences between 2 percentages:
where P is equal to (p 1 * N 1 1 p 2 * N 2 )/(N 1 1 N 2 ), and
Differences between percentages and estimated differences between mean values were used for 2-sided tests. Statistical significance was assumed when P < .05. Accumulative curves were created by adding each new value to the previous set of values until all values were included. Linear regression analysis was performed for the correlation test. The study design was approved by the Ethics Committee at Karolinska Institute (Stockholm, Sweden; 2013/707-31/3).
RESULTS
Mammography Screening
The main effect of breast cancer screening is earlier detection of tumors and reduced tumor size at diagnosis, presumably resulting in tumors with lower metastatic potential, decreased genomic instability, and reduced mortality. 22 In the FNAB and CNB cohorts, patients who underwent either surgery plus postoperative radiotherapy or surgery alone were investigated according to 3 tumor (Table 1) and were selected for follow-up of metastasis, thereby avoiding the screening effect. A flow chart of the selection process used to reach the final sample for analysis is provided in Figure 1 .
Distribution Treatments Within the 2 Patients Cohort
Among patients who had tumors 30 mm, the distributions of those who underwent surgery plus postoperative radiotherapy versus surgery alone in the 2 decades are detailed in Table 2 . In total, 69% (n 5 140) of patients in the CNB cohort underwent surgery plus postoperative radiotherapy compared with 53% (n 5 96) in the FNAB cohort (P < .02). Thus, surgery alone was more frequent in the same FNAB cohort (P < .05) ( Table 2 ) (see Discussion, below). There was no difference in age distribution between the 2 treatment groups (Table 3) ; therefore, no age-guided selection was performed for either of the 2 treatments.
LOCMs and DISTMs in the 2 Patient Cohorts
To evaluate the difference of LOCMs and DISTMs between the 2 cohorts in a stepwise manner, metastases were arranged according to accumulating mean monthly values reached from diagnosis to 180 months (15 years) and registered at intervals of every 5 months. In every interval, there was a mixture of early and late-occurring metastases after diagnosis, together establishing the increasing mean monthly values. These results generated curves of DISTMs and LOCMs from diagnosis to 180 months (Figs. 2 and 3 ). After accumulating all 5-year intervals, the 
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curves ended with a final mean value from detected metastases that included all DISTMs and LOCMs. Figure 2a illustrates DISTMs from the CNB and the FNAB cohorts. Starting approximately 25 months after diagnosis, an increase in the rate of DISTMs was observed in patients from the CNB cohort compared with the FNAB cohort, and this difference became more pronounced after 60 months. The 2 curves continued to diverge to the endpoint at180 months after diagnosis (Fig. 2a) . Comparison of the mean monthly values reached at the end of the curves revealed statistically significant differences between the 2 cohorts (Fig. 2a) . No significant difference in the accumulating rates of LOCMs was noted (Fig. 2b) . After 120 months, no additional LOCMs appeared in the FNAB cohort, but additional LOCMs continued to appear up to 180 months in the CNB cohort (Fig. 2b) . Visualization of the LOCMs and DISTMs within each decade again revealed a significantly higher rate of DISTMs than LOCMs in the CNB cohort (Fig. 3a) , but no such difference was observed in the FNAB cohort (Fig. 3b) .
DNA Ploidy Analysis
DNA ploidy analysis of patients diagnosed in the 1970s and 1990s was performed using the entire original samples, as presented in Figure 1 , as well as the final selected FNAB and CNB cohorts based on the unified sample (surgery alone and surgery plus postoperative radiotherapy). The results revealed no differences in distribution according to DNA ploidy between either the 2 original cohorts or the 2 final FNAB and CNB cohorts or between the original and final selected cohorts (Table 4) . Therefore, we analyzed the entire original samples in Table 5 and observed no significant differences in DNA-ploidy distribution in those diagnosed 60 months before or after diagnosis. However, there was a trend towards increased aneuploid tumors and a reduction in diploid tumors <60 months after diagnosis in the FNAB cohort, although this could not be confirmed because the sample was too small in the interval !60 months (Table 5 ). In the FNAB cohort, 24% of DISTMs appeared 60 months after diagnosis. In the CNB cohort, 43.5% of DISTMs appeared in the same time interval, The cohorts were rather small. A minimum of 90 patients in both groups was needed to reach statistical significance.
generating a statistically significant difference (P < .05) ( Table 5) .
DISCUSSION
In the current study, we compared matched cohorts of patients with breast cancer who underwent FNAB and CNB. By including only patients who had tumors measuring 30 mm in greatest dimension, we avoided a mammography screening effect (Table 1) . Large tumors (>30 mm) were mainly diagnosed during the first 6 to 8 years after the introduction of mammography screening. 23 DNA-ploidy analysis of tumors diagnosed in the 1970s and 1990s revealed concordant stepwise percentages from genomically stable diploid tumors to more genomically unstable tetraploid to aneuploid tumor types, indicating that the cohorts included tumors with a similar distribution of DNA-ploidy types in both the original and final selected samples (Table 4 ). In addition, it is important to note that all patients who were included in the final selected cohorts underwent either surgery plus postoperative radiotherapy or surgery alone. No patients received additional adjuvant treatments, such as hormone therapy or chemotherapy. The only difference regarding treatment was that patients in the CNB cohort more frequently received postoperative radiotherapy. This may have reduced the number of seeding cells leaving the primary tumor region and, thus, local recurrence, in the CNB cohort. However, we still observed a significantly higher rate of DISTMs in the CNB cohort (Figs. 2a and 3a) and a significantly higher frequency of DISTMs (Table 5 ). To Abbreviations: R, summation; CNB, core-needle biopsy; FNAB, fine-needle aspiration biopsy; NS, nonsignificant. a Comparisons of DNA ploidy were performed between unselected samples of patients from the 1970s (n 5 354) and the 1990s (n 5 1729) and the 2 final selected cohorts of FNAB (n 5 181) and CNB (n 5 203), as presented in Figure 1 . The ploidy entities included were diploidy, tetraploidy, and aneuploidy, and no significant difference in distribution according to ploidy was observed. Values in the bottom row (R) represent the numbers who had DNA data available in each group.
allow sufficient time for metastases to emerge and become clinically evident, we followed all patients for 15 years after diagnosis to include late recurrences because of a slow growth rate or a period of dormancy, 26 and we mapped the LOCMs and DISTMs (Figs. 2 and 3 ). No significant difference in LOCMs was observed between the 2 patient groups, and LOCMs did not appear after 120 months in the FNAB cohort, but they continued to emerge to the end of observation at 180 months in the CNB cohort (Fig.  2b) . DISTMs outnumbered LOCMs in the CNB cohort; whereas, in the FNAB cohort, DISTMs and LOCMs appeared at roughly equal levels (Fig. 3a,b) . We believe that the underlying cause may be higher numbers of dislodged cells after CNB. Other complex processes, such as biopsy-induced inflammation, may contribute to the increased rate of late DISTMs observed in this study. We urge future studies to address these issues: First, the area or volume of biopsy-related trauma is an important parameter associated with the risk of inflammatory reaction and tumor-cell dissemination caused by dispersed energy. The average needle velocity for FNAB is a few centimeters per second, whereas that for springloaded CNB is approximately 500 to 1000 times faster. The trauma area is proportional to the square of the needle diameter (0.5-0.7 mm for FNA and 1.25-3.0 mm for CNB) as well as the energy generated by velocity. 21 Several complex phenomena might occur and contribute to tissue damage and, in turn, seeding of metastases when using high-velocity needles, such as standing wave formation, microstreaming, energy conversion, and pumping effects with time for balance. Pressure-driven cavitation might even occur in some patients. Second, the literature on cancer cell seeding caused by different biopsy methods includes diverse opinions regarding the risk of LOCMs and DISTMs originating from disseminated cancer cells. Generally, there is a lack of studies with large patient numbers, long enough follow-up, and adequate control groups. However, it has been demonstrated that micrometastases develop in multiple organs after the transplantation of spheres from core biopsies of human breast cancer into the mammary fat pad of nude mice. 24 These micrometastases can be documented relatively quickly. However, the appearance of macrometastases seems to be delayed beyond the time frame expected based on the proliferation rate of the original implanted tumor. This dormancy period before the outgrowth of macrometastases may explain why DISTMs in our study were increased in the CNB cohort starting at 5 years after primary diagnosis, and not sooner. 25 In 2 different mouse models of restricted, controlled systems, diagnostic CNB of breast tumors before their surgical removal was associated with a higher rate of distant lung and liver metastases compared with the rate after surgical removal alone. 17, 18 An important factor in the immunologic response to tissue trauma is the macrophage polarization from M1 to M2, which may accelerate tumor progression, as observed in oral squamous cell carcinoma. Weber and coworkers 26 concluded that transition from M1 to M2 is a consequence of preoperative CNB. In summary, we hypothesized that the higher amount of absorbed energy caused by CNB compared with FNAB might increase the intratumor inflammatory reaction, which, combined with tumor seeding, results in increased DISTMs. However, our current study does not contribute sufficient data to support that hypothesis. In a published report, inflammation, wound healing, and metastatic invasion were observed in the tumor area surrounding the needle channel after CNB in patients with breast cancer. Abbreviations: R, summation; CNB, core-needle biopsy; FNAB, fine-needle aspiration biopsy; NS, nonsignificant. a In the FNAB cohort, the 3 DNA ploidy entities of diploid, tetraploid, and aneuploid revealed no significant differences between early (<60 months) and late appearing metastases (!60 months), although there was a strong trend towards more aneuploid tumors for the time interval <60 months (33.3%) compared with ! 60 months (13.5%). The number of patients who developed distant metastasis in !60 months was too small to reach significance. Most distant metastases appeared <60 months after diagnosis (P <.0001) b In the CNB cohort, no significant differences in ploidy entities were observed when comparing the periods 60 months before and 60 months after diagnosis, and the differences in the numbers of patients who developed distant metastases 60 months before and 60 months after diagnosis were smaller compared with those in the FNAB cohort, although they were still statistically significant (P <.01).
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The current findings have implications for clinical practice. CNB as a diagnostic tool seems to dislodge tumor cells before postoperative radiation therapy. Those cells are capable of establishing metastases at distant locations, which become evident after a period of dormancy or slow growth (>5 years after diagnosis) in a significant subset of patients. However, there are several clinical situations in which CNB will still be the method of choice, as in the case of highly sclerotic lesions, microcalcifications not associated with mass lesions, and discrepancies between radiologic and cytologic findings.
To reduce the risk of biopsy-induced perturbations, including distant dissemination of tumor cells, we propose reestablishing FNAB biopsy combined with molecular analysis as the primary procedure of choice equipped with, for instance, an antiseeding device. 28 It was recently reported that FNAB-acquired cell blocks fixed in 10% formalin had very high concordance compared with analyses of estrogen and progesterone receptors on tissue blocks from surgical specimens, as did human epidermal growth factor receptors using an immune histochemistry method. 29 Recent developments in advanced molecular cancer analysis, as currently established at many clinical research laboratories, have opened a new possibility of using minimal FNAB material for objective, highly sensitive, molecular-based diagnostics. 30 
FUNDING SUPPORT
This work was supported by the Karolinska Institutet Fund.
